Subramanian Arun, Wanta Brendan T, Fogelson Jeremy L, Curry Timothy B, Hannon James D
Departments of *Anesthesiology and †Neurosurgery, Mayo Clinic Rochester, Rochester, MN.
Spine (Phila Pa 1976). 2014 Oct 1;39(21):1758-64. doi: 10.1097/BRS.0000000000000509.
Retrospective cohort study.
This study compares time to extubation between major spine surgery patients anesthetized with fentanyl versus sufentanil infusions in combination with propofol.
In patients undergoing spinal fusion with intraoperative electrophysiological monitoring of the spinal cord, total intravenous anesthesia with a propofol/opioid combination results in better electrophysiological signals compared with volatile anesthetics. Pharmacokinetic data suggest that total intravenous anesthesia with sufentanil should lead to more rapid emergence from anesthesia than with fentanyl. However, this has never been tested in the spine surgery patient population.
With institutional review board approval, all major spine patients receiving a propofol-based total intravenous anesthesia with fentanyl were compared with those receiving sufentanil. Time to extubation, defined as the time from surgical closure to tracheal extubation, was the study outcome. Relevant demographic, anthropomorphic, anesthetic, and surgical data were collected. Association between type of opioid and time to extubation was tested for statistical significance. Multiple linear regression analysis was used to control for confounders.
A total of 167 patients met inclusion criteria (fentanyl = 72, sufentanil = 95). There was no statistically significant difference between the 2 groups in terms of baseline characteristics. Time from surgical closure to extubation in the fentanyl versus sufentanil groups was not statistically different (mean [SD]: 40.2 [26.7] min vs. 45.0 [36.9] min; P = 0.36). On multivariate analysis, total dose of propofol and male sex were associated with increased time to extubation.
The use of sufentanil may not reduce time to extubation compared with fentanyl despite its favorable pharmacokinetic profile. Higher doses of propofol and male sex were associated with longer time to extubation and seem to play a greater role than choice of opioid.
回顾性队列研究。
本研究比较接受芬太尼或舒芬太尼输注联合丙泊酚麻醉的脊柱大手术患者的拔管时间。
在接受脊髓术中电生理监测的脊柱融合手术患者中,与挥发性麻醉剂相比,丙泊酚/阿片类药物联合的全静脉麻醉可产生更好的电生理信号。药代动力学数据表明,与芬太尼相比,舒芬太尼全静脉麻醉应能使患者更快从麻醉中苏醒。然而,这从未在脊柱手术患者群体中得到验证。
经机构审查委员会批准,将所有接受以丙泊酚为基础的芬太尼全静脉麻醉的脊柱大手术患者与接受舒芬太尼的患者进行比较。拔管时间定义为从手术结束到气管拔管的时间,为研究结果。收集相关的人口统计学、人体测量学、麻醉和手术数据。检验阿片类药物类型与拔管时间之间的关联是否具有统计学意义。采用多元线性回归分析来控制混杂因素。
共有167例患者符合纳入标准(芬太尼组 = 72例,舒芬太尼组 = 95例)。两组在基线特征方面无统计学显著差异。芬太尼组和舒芬太尼组从手术结束到拔管的时间无统计学差异(均值[标准差]:40.2[26.7]分钟对45.0[36.9]分钟;P = 0.36)。多因素分析显示,丙泊酚总剂量和男性与拔管时间延长相关。
尽管舒芬太尼具有良好的药代动力学特征,但与芬太尼相比,使用舒芬太尼可能不会缩短拔管时间。丙泊酚剂量较高和男性与拔管时间较长相关,似乎比阿片类药物的选择发挥更大作用。
3级。